A novel anti-epileptic agent, perampanel, selectively inhibits AMPA receptor-mediated synaptic transmission in the hippocampus
- 30 September 2012
- journal article
- Published by Elsevier BV in Neurochemistry International
- Vol. 61 (4), 517-522
- https://doi.org/10.1016/j.neuint.2012.02.035
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Topiramate Reduces Excitability in the Basolateral Amygdala by Selectively Inhibiting GluK1 (GluR5) Kainate Receptors on Interneurons and Positively Modulating GABAA Receptors on Principal NeuronsJournal of Pharmacology and Experimental Therapeutics, 2009
- Capabilities of the WinLTP data acquisition program extending beyond basic LTP experimental functionsJournal of Neuroscience Methods, 2007
- Lacosamide: A Review of Preclinical PropertiesCNS Drug Reviews, 2007
- AMPA Receptor Antagonists as Potential Anticonvulsant DrugsCurrent Topics in Medicinal Chemistry, 2005
- Kainate receptors and the induction of mossy fibre long-term potentiationPhilosophical Transactions Of The Royal Society B-Biological Sciences, 2003
- A crossover, add-on trial of talampanel in patients with refractory partial seizuresNeurology, 2002
- The New Generation of GABA EnhancersCNS Drugs, 2001
- Kainate receptors are involved in synaptic plasticityNature, 1999
- Neuropharmacology of AMPA and kainate receptorsNeuropharmacology, 1998
- Chapter 24 Glutamate receptors in epilepsyProgress in brain research, 1998